New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For VVUS;TSN;DELL;ALKS;MCK;GDOT;MRK;LTM;NFLX;CTRP;ADNC;ELN;MAT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
February 23, 2015
08:27 EDTMRKNGM Biopharmaceuticals to hold a teleconference
NGM Biopharm discusses the strategic collaboration with Merck to discover, develop and commercialize novel biologic therapeutics on a teleconference to be held on February 23 at 9:30 am. Webcast Link
07:04 EDTMRKMerck, NGM Biopharmaceuticals announce multi-year collaboration
NGM Biopharmaceuticals and Merck announced they have entered into a multi-year collaboration to research, discover, develop and commercialize novel biologic therapies across a wide range of therapeutic areas. This agreement will become effective upon the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act. The collaboration includes multiple drug candidates currently in preclinical development at NGM, including NP201, which is being evaluated for the treatment of diabetes, obesity and nonalcoholic steatohepatitis. NGM will lead the research and development of the existing preclinical candidates and have the autonomy to identify and pursue other discovery stage programs at its discretion. Merck will have the option to license all resulting NGM programs following human proof of concept trials. If Merck exercises this option, Merck will lead global product development and commercialization for the resulting products, if approved. Under the terms of the agreement, Merck will make an upfront payment to NGM of $94M and will purchase a 15 percent equity stake in NGM for $106M at a price per share that represents a 20% premium to NGM’s most recent financing. Merck will commit up to $250M to fund all of NGM’s efforts under the initial five-year term of the collaboration, with the potential for additional funding if certain conditions are met. Prior to Merck initiating a Phase 3 study for a licensed program, NGM may elect to either receive milestone and royalty payments or, in certain cases, to co-fund development and participate in a global cost and revenue share arrangement of up to 50%. The agreement also provides NGM with the option to participate in the co-promotion of any co-funded program in the United States. Merck will have the option to extend the research agreement for two additional two-year terms.
February 20, 2015
07:08 EDTMRKAmerican Academy of Allergy, Asthma and Immunology to hold annual meeting
2015 Annual Meeting of AAAAI is being held in Houston, Texas on February 20-24.
February 19, 2015
16:01 EDTNFLXOptions Update; February 19, 2015
iPath S&P 500 VIX Short-Term Futures down 70c to 30.11. Option volume leaders: AAPL TSLA TWTR AMAT PBR KO FB AXP NFLX according to Track Data.
14:38 EDTTSNGovernment panel continues to recommend lean meat, Bloomberg says
Subscribe for More Information
08:38 EDTMRKNewLink reports clinical development milestone achieved with Merck for rVSV-EBOV
NewLink Genetics (NLNK) announced that it had received notification from Merck (MRK) that the milestone event specified in the license and collaboration agreement between the two companies relating to the further development of the rVSV-EBOV, Ebola, vaccine candidate had been achieved. Under the terms of the agreement, NewLink Genetics will receive a payment of $20M in connection with the achievement of the milestone. The milestone pertains to the initiation of a key clinical trial for the vaccine.
February 18, 2015
16:00 EDTNFLXOptions Update; February 18, 2015
Subscribe for More Information
12:53 EDTADNCVertex raises stake in Audience to 7.3% from 5.1%
09:37 EDTNFLXOption volume leaders on open
Option volume leaders: AAPL TSLA TWTR CELG APO NFLX AXP APA LNKD C GILD according to Track Data.
February 13, 2015
16:58 EDTLTMGreenlight Capital gives quarterly update on stakes
Subscribe for More Information
09:33 EDTMATMattel, Google confirm View-Master toy collaboration
Mattel (MAT), at the Toy Industry Association’s Toy Fair in New York, unveiled a collaboration with Google (GOOG, GOOGL) via which the two will launch a new "virtual reality" View-Master toy. Available fall 2015, consumers can purchase the View-Master viewer and a sample experience reel for SRP $29.99. Additional experience reel packs will be sold separately at retail for SRP $14.99.
08:19 EDTMRKAckman noncommittal on McDonald's rumors, Bloomberg reports
Subscribe for More Information
06:08 EDTMATAmerican Girl partners with Fashion Angels on licensing deal
American Girl, a division of Mattel, announced a licensing agreement with Fashion Angels, the designer of tween girls’ lifestyle and activity products, to create a variety of trend-right and fashion-focused arts & crafts products. The new line will be available this fall at retailers nationwide and will include activity kits, fashion sketchbooks, and Do-It-Yourself craft kits for girls to create fun accessories for themselves and their favorite American Girl dolls.
February 12, 2015
17:52 EDTTSNConAgra, Campbell drop after lowering yearly view on FX headwinds
Shares of food product companies ConAgra Food (CAG) and Campbell Soup Company (CPB) are trading lower in extended trading after both companies issued profit warnings as a result of currency headwinds. WHAT'S NEW: After the closing bell, ConAgra said it sees third quarter earnings per share 10c below the 62c it earned in the same quarter last year. Consensus estimates for ConAgra's Q3 EPS are currently 61c. The company also lowered its EPS view for 2015 to $2.13-$2.18 against consensus estimates of $2.26. The company said, "A strengthening dollar has negatively impacted the EPS outlook, as has a higher-than-planned mark-to-market loss from certain commodity index hedges as discussed in the company’s fiscal second-quarter earnings release. Two operating issues account for the majority of the change in EPS expectations: Profitability for the Private Brands segment is weaker than planned due to a highly competitive bidding environment, as well as execution shortfalls, which together have negatively impacted recent results and near-term expectations for volumes, pricing, and margins.The ongoing longshoremen labor dispute on the U.S. West Coast has continued longer than the company expected, which has negatively impacted exports of Lamb Weston potato products to international markets." Another food company, Campbell Soup Company, lowered its second quarter and full year 2015 guidance after the closing bell. Campbell's gave second quarter EPS guidance of 65c-66c, which was below consensus estimates, and added that net sales for Q2 will decline by approximately 2%, reflecting the negative impact of currency translation. The company estimates that Q2 adjusted EBIT will decline by approximately 17%, due primarily to lower gross margin performance and the negative impact of currency translation. Campbell lowered its FY15 EPS view to $2.32-$2.38 against a consensus estimate of $2.45. PRICE ACTION: Campbell Soup Company is trading lower by 4.2% to $45.70 in extended trading while ConAgra shares are 2.75% lower to $35.42. OTHERS TO WATCH: Other food product companies include General Mills (GIS), Kraft Foods Group (KRFT), Mondelez International (MDLZ), Tyson Foods (TSN), Dean Foods (DF), The WhiteWave Foods Company (WWAV), and J M Smucker (SJM).
16:34 EDTTSNConAgra announces Sean Connolly as new CEO
Subscribe for More Information
15:14 EDTMATMattel to host analyst meeting
Subscribe for More Information
14:25 EDTMATMattel, Viacom expand licensing partnership with TMNT construction toy line
MEGA Brands, a business of Mattel (MAT), announced a new Teenage Mutant Ninja Turtles construction toy line, expected to hit shelves in 2016, at New York Toy Fair. Nickelodeon and all related titles, characters and logos are trademarks of Viacom (VIA, VIAB).
10:00 EDTCTRPOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:13 EDTNFLXSeason 3 of 'House of Cards' briefly available on Netflix Wednesday, CNBC says
Subscribe for More Information
05:27 EDTCTRPCtrip.com downgraded to Perform from Outperform at Oppenheimer
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use